Literature DB >> 19218710

Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis.

K Zycinska1, K A Wardyn, T M Zielonka, U Demkow, M S Traburzynski.   

Abstract

Wegener's granulomatosis is a systemic disease characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract and necrotizing crescentic glomerulonephritis. Nasal carriage of S. aureus is considered a risk factor for S. aureus infections. The aim was to examine possible risk factors for relapse including refractory nasal carriage of Staphylococcus aureus in patients with Wegener's granulomatosis. Swab cultures from anterior nares for S. aureus were taken in consecutive patients (n=28), with limited (n=15) and systemic forms (n=13) of biopsy-proven Wegener's granulomatosis. The occurrence of infection and relapses were identified according to defined criteria. Seventeen of the 28 patients (60%: 95% Cl, 41-76%) were found to be chronic nasal carriers of S. aureus (> or =80% of nasal cultures positive for S. aureus). A hazard regression analysis identified chronic nasal carriage of S. aureus as independent risk factor for relapse (HR-4.56; Cl 2.45-7.65) in patients with limited Wegener's granulomatosis. Chronic nasal carriage of S. aureus characterized patients with Wegener's granulomatosis, who are more prone to relapses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218710

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  18 in total

Review 1.  Risk factors for treatment failures in antineutrophil cytoplasmic antibody- associated small-vessel vasculitis.

Authors:  Vijay R Karia; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

2.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

3.  Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.

Authors:  Jun-Jun Luan; Guang-Qun Xing
Journal:  J Nephrol       Date:  2016-07-30       Impact factor: 3.902

Review 4.  Pulmonary vasculitis.

Authors:  Ana Casal; Juan Díaz-Garel; Tara Pereiro; María E Toubes; Jorge Ricoy; Luis Valdés
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 5.  ANCA-Associated Vasculitis Pathogenesis: A Commentary.

Authors:  Eric J Gapud; Philip Seo; Brendan Antiochos
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

6.  Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis.

Authors:  Henko Tadema; Cees G M Kallenberg; Coen A Stegeman; Peter Heeringa
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

7.  Upper respiratory tract symptoms, renal involvement and vasculitis: a case report and review of wegener granulomatosis.

Authors:  Mohd Shahrir Mohamed Said
Journal:  J Clin Med Res       Date:  2010-08-18

8.  Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis.

Authors:  Henko Tadema; Wayel H Abdulahad; Coen A Stegeman; Cees G M Kallenberg; Peter Heeringa
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

Review 9.  The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review.

Authors:  Andreas Kronbichler; Julia Kerschbaum; Gert Mayer
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

10.  Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis.

Authors:  Janet Wohlers; Katrin Breucker; Rainer Podschun; Jürgen Hedderich; Peter Lamprecht; Petra Ambrosch; Martin Laudien
Journal:  Arthritis Res Ther       Date:  2012-10-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.